The BCR-ABL protein triggers bone marrow to keep making abnormal versions of white blood cells, which are the leukemia cells. The BCR-ABL gene and BCR-ABL protein are the key causes of Ph+ CML. The resulting uncontrolled growth of these leukemia cells can cause a large increase in their concentration in the blood. Over time, these abnormal cells crowd out healthy red blood cells and platelets as well as normal white cells, which can have negative effects on your health.
Treating CML
Targeted Ph+ CML therapies have been developed to slow the reproduction of leukemia cells. These therapies work to reduce the levels of cancer-causing proteins and Ph+ CML cells. Some patients who respond exceptionally well to treatment may achieve a level of leukemic cells that is nearly undetectable.
As with any condition, it is important to take your medication as prescribed and directed by your doctor. It is also important to get the most accurate test possible at each step of your journey, as this will enable you and your doctor to see if your treatment is working. 
Questions to ask your doctor
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Understanding Ph+ CML
In Ph+ CML, the abnormal Philadelphia chromosome is created when parts of two separate genes within a cell's DNA switch places. »
Treating Ph+ CML
The goal of treatment is to decrease the level of leukemic cells. CML treatment can be thought of as a series of steps or milestones. »
Meet the Milestones that Matter
Checkpoints on a Ph+ CML patient's journey indicate response to treatment. Each level of reduction in leukemic cells is called a treatment milestone. » Source URL: https://www.novartis.com/our-focus/cancer/oncology-disease-areas/chronic-myeloidleukemia
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